Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery

Eur J Cardiothorac Surg. 2006 Dec;30(6):852-72. doi: 10.1016/j.ejcts.2006.09.003. Epub 2006 Oct 27.

Authors

Joel Dunning¹, Tom Treasure, Michael Versteegh, Samer A M Nashef; EACTS Audit and Guidelines Committee

Affiliation

¹ James Cook University Hospital, Middlesbrough, UK.

PMID: 17070065
DOI: 10.1016/j.ejcts.2006.09.003

No abstract available

Publication types

Practice Guideline
Review

MeSH terms

Adrenergic beta-Antagonists / therapeutic use
Amiodarone / therapeutic use
Anti-Arrhythmia Agents / therapeutic use
Atrial Fibrillation / etiology*
Atrial Fibrillation / prevention & control
Atrial Fibrillation / therapy*
Evidence-Based Medicine
Humans
Magnesium / therapeutic use
Postoperative Care / methods*
Sotalol / therapeutic use
Thoracic Surgical Procedures / adverse effects*

Substances

Adrenergic beta-Antagonists
Anti-Arrhythmia Agents
Sotalol
Magnesium
Amiodarone